{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:44:13Z","timestamp":1786167853270,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Senju Pharmaceutical Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10384-026-01362-z","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:43:39Z","timestamp":1778229819000},"page":"983-990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of physician-assessed and patient-reported outcomes of using azithromycin eye drops in the treatment of bacterial blepharitis"],"prefix":"10.1007","volume":"70","author":[{"given":"Takashi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Nejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saichi","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Todokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michikazu","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"1362_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ophtha.2018.10.019","volume":"126","author":"G Amescua","year":"2019","unstructured":"Amescua G, Akpek EK, Farid M, Garcia-Ferrer FJ, Lin A, Rhee MK, et al. Blepharitis preferred practice pattern\u00ae. Ophthalmology. 2019;126:56\u201393.","journal-title":"Ophthalmology"},{"key":"1362_CR2","unstructured":"Eberhardt M, Zeppieri M, Rammohan G. Blepharitis. StatPearls [Internet]. StatPearls Publishing; 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459305"},{"key":"1362_CR3","first-page":"423","volume":"17","author":"S Suzuki","year":"2000","unstructured":"Suzuki S, Yokoi N, Sano Y, Kinoshita S. Clinical study of corneal epithelial damage related to meibomitis (meibomitis-related keratopathy). Journal of the Eye. 2000;17:423\u20137 ((in Japanese)).","journal-title":"Journal of the Eye"},{"key":"1362_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jtos.2014.12.002","volume":"13","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Teramukai S, Kinoshita S. Meibomian glands and ocular surface inflammation. Ocul Surf. 2015;13:133\u201349.","journal-title":"Ocul Surf"},{"issue":"2 Suppl","key":"1362_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1542-0124(12)70620-1","volume":"7","author":"MA Lemp","year":"2009","unstructured":"Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7(2 Suppl):S1\u201314.","journal-title":"Ocul Surf"},{"key":"1362_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/ICO.0b013e3181ca38a0","volume":"29","author":"RM Haque","year":"2010","unstructured":"Haque RM, Torkildsen GL, Brubaker K, Zink RC, Kowalski RP, Mah FS, et al. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea. 2010;29:871\u20137.","journal-title":"Cornea"},{"key":"1362_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/IIO.0b013e31822d6af1","volume":"51","author":"P Veldman","year":"2011","unstructured":"Veldman P, Colby K. Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness. Int Ophthalmol Clin. 2011;51:43\u201352.","journal-title":"Int Ophthalmol Clin"},{"key":"1362_CR8","unstructured":"Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare. Guidelines for clinical evaluation methods of ocular topical antimicrobial agents. PSEHB Notification;0418\u20131, dated April 18, 2019."},{"key":"1362_CR9","first-page":"999","volume":"39","author":"R Nejima","year":"2022","unstructured":"Nejima R, Inoue T, Kaji Y, Suzuki T, Hattori T, Hoshi S, et al. Analysis of treatment protocols using azithromycin eye drops for bacterial blepharitis\u2014first report: study of clinical course. J Eye. 2022;39:999\u20131004 ((in Japanese)).","journal-title":"J Eye"},{"key":"1362_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0839-5","volume":"16","author":"K Hosseini","year":"2018","unstructured":"Hosseini K, Bourque LB, Hays RD. Development and evaluation of a measure of patient-reported symptoms of blepharitis. Health Qual Life Outcomes. 2018;16:11.","journal-title":"Health Qual Life Outcomes"},{"key":"1362_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1444-0938.2010.00540.x","volume":"94","author":"DL Opitz","year":"2011","unstructured":"Opitz DL, Tyler KF. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Clin Exp Optom. 2011;94:200\u20136.","journal-title":"Clin Exp Optom"},{"key":"1362_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/ICL.0b013e3182658699","volume":"38","author":"M Guillon","year":"2012","unstructured":"Guillon M, Maissa C, Wong S. Symptomatic relief associated with eyelid hygiene in anterior blepharitis and MGD. Eye Contact Lens: Sci Clin Pract. 2012;38:306\u201312.","journal-title":"Eye Contact Lens: Sci Clin Pract"},{"key":"1362_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/jop.2017.0095","volume":"34","author":"E Yildiz","year":"2018","unstructured":"Yildiz E, Yenerel NM, Turan-Yardimci A, Erkan M, Gunes P. Comparison of the clinical efficacy of topical and systemic azithromycin treatment for posterior blepharitis. J Ocul Pharmacol Ther. 2018;34:365\u201372.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1362_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s10384-022-00965-6","volume":"66","author":"R Nejima","year":"2022","unstructured":"Nejima R, Eguchi H, Todokoro D, Inoue T, Kaji Y, Suzuki T, et al. Correction to: analysis of treatment protocols using azithromycin eye drops for bacterial blepharitis: second report\u2014bacteriological investigation. Jpn J Ophthalmol. 2022;66:590\u20131.","journal-title":"Jpn J Ophthalmol"},{"key":"1362_CR15","unstructured":"Azimycin ophthalmic solution 1%. Package insert. Senju Pharmaceutical Co, Ltd; 2020. Accessed January 11, 2022. https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/380086_1317714Q1024_1_05. (in Japanese)"},{"key":"1362_CR16","first-page":"627","volume":"27","author":"S Amano","year":"2010","unstructured":"Amano S, Arita R, Kinoshita S, Yokoi N, Sotozono C, Komuro A, et al. Definition and diagnostic criteria for meibomian gland dysfunction. J Eye. 2010;27:627\u201331 ((in Japanese)).","journal-title":"J Eye"},{"key":"1362_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033940","volume":"9","author":"A Midorikawa-Inomata","year":"2019","unstructured":"Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, et al. Reliability and validity of the Japanese version of the ocular surface disease index for dry eye disease. BMJ Open. 2019;9:e033940.","journal-title":"BMJ Open"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01362-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01362-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01362-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:22:58Z","timestamp":1786166578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01362-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01362-z","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T. Suzuki, Payment or honoraria for lectures (Senju, Santen, Otsuka, Novartis); R. Nejima, Payment or honoraria for lectures (Senju, Santen, Otsuka); T. Inoue, None; Y. Kaji, None; T. Hattori, Payment or honoraria for lectures (Senju); S. Hoshi, None; D. Todokoro, Payment or honoraria for lectures (Senju, Santen); H. Eguchi, None; M. Nakai, None; Y. Inoue, Payment or honoraria for lectures (Senju, Santen).","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}